Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2009-04-20 Annual Report
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
Annual Report 2008
Annual Report Classification · 100% confidence The document is a comprehensive annual report for RaySearch Laboratories for the year 2008. It contains detailed financial statements (income statements, balance sheets, cash flow analysis), management's discussion and analysis (VD-ord, business strategy, market trends), and governance information. It is clearly a full annual report, not an announcement or a summary, as evidenced by the table of contents and the extensive financial and operational data provided. FY 2008
2009-04-20 Swedish
Major Shareholding Notification 2009
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder (Wasatch Advisors, Inc) in RaySearch Laboratories AB (publ). It explicitly shows the 'Before the transaction' and 'After the transaction' share quantities and percentages, culminating in a notification about crossing a threshold ('Limit for number of shares' and 'Limit for number of votes' are mentioned, suggesting a notification requirement). This structure perfectly matches the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2009-03-09 English
Audit Report / Information 2008
Audit Report / Information Classification · 95% confidence The document is titled "RaySearch Laboratories AB (publ) Bokslutskommuniké 2008" and presents key financial figures for the period "1 JANUARI – 31 DECEMBER 2008" (Full Year 2008) and the fourth quarter (okt-dec). It includes a summary of financial results, management commentary on the year's performance, and details significant events that occurred during the period and after the period end. The term 'Bokslutskommuniké' translates to 'Year-end report communication' or 'Year-end financial report release'. Since it provides the full year's financial summary and management discussion, it aligns closely with the content of an Annual Report (10-K) or a comprehensive Interim Report (IR), but specifically for the full year. Given the context of financial reporting, a full-year report summarizing performance is typically classified as a 10-K if it's the official SEC filing, or sometimes an AR if it's a standalone audit/financial summary. However, this document reads like a comprehensive year-end financial summary released by the company, which often precedes or is equivalent to the detailed Annual Report filing. Since it contains detailed financial tables and management analysis for the full year, it is more substantial than a mere Earnings Release (ER). In the context of the provided definitions, the closest fit for a comprehensive, full-year financial report summary is the Annual Report (10-K), although it is a Swedish 'Bokslutskommuniké'. If it were a quarterly report, it would be IR. Given it covers the full year (Jan-Dec), 10-K is the most appropriate classification for a comprehensive annual financial disclosure. FY 2008
2009-02-11 Swedish
Interim / Quarterly Report 2008
Interim / Quarterly Report Classification · 100% confidence The document is a 'Year-end Report' for RaySearch Laboratories AB for the fiscal year 2008. It contains comprehensive financial statements, including net sales, operating profit, net profit, and earnings per share for both the full year and the fourth quarter. It also includes detailed management commentary, analysis of business trends, and operational highlights. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year (the fourth quarter) and the full fiscal year, it qualifies as an Interim/Quarterly Report (IR). FY 2008
2009-02-11 English
Regulatory Filings 2009
Regulatory Filings Classification · 98% confidence The document is a press release announcing that a new software product, SharePlan™, resulting from a collaboration between RaySearch and TomoTherapy, has received 510(k) clearance from the FDA. This is a specific operational/product development update, not a standard periodic financial report (like 10-K or IR), nor is it a management change (MANG) or a dividend announcement (DIV). It relates to a significant business event—product approval and market launch potential. Since there is no specific category for 'Product Approval Announcement' or 'Business Update,' and it is not a general regulatory filing (RNS) or a financing event (CAP), the most appropriate classification among the provided options is 'Regulatory Filings' (RNS) as a general announcement, or potentially 'LTR' if the FDA clearance is viewed as a regulatory milestone. However, given the context of a press release announcing a specific business achievement (product clearance), and lacking a better fit, RNS serves as the best general regulatory/business announcement fallback. Given the short length and press release format, it is not a comprehensive report. I will classify it as RNS as a general regulatory/business announcement.
2009-01-27 English
Regulatory Filings 2009
Regulatory Filings Classification · 99% confidence The document is titled "PRESSMEDDELANDE" (Press Release) and announces that a new software solution, SharePlan™, developed through a collaboration between RaySearch and TomoTherapy, has received FDA 510(k) clearance and can now be launched on the market. It includes quotes from the CEOs/VPs and background information on both companies. This is a general corporate announcement regarding a product milestone/regulatory achievement, not a comprehensive financial report (like 10-K or IR), a specific shareholder vote result (DVA), or a management/board change (MANG). Since it is a press release announcing a significant business event (product launch following regulatory approval), and it doesn't fit the specific categories like ER (Earnings Release) or CAP (Financing Update), the most appropriate general category for a significant, non-financial regulatory/product announcement that doesn't fit elsewhere is Regulatory Filings (RNS), as it functions as a general regulatory disclosure/news release.
2009-01-27 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.